PureTech Health plc (NASDAQ:PRTC) Short Interest Up 77.7% in December

PureTech Health plc (NASDAQ:PRTC) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 35,900 shares, a growth of 77.7% from the December 15th total of 20,200 shares. Based on an average daily volume of 4,500 shares, the days-to-cover ratio is currently 8.0 days.

PureTech Health Price Performance

PRTC traded up $0.10 during trading hours on Friday, hitting $18.19. 13,996 shares of the company’s stock were exchanged, compared to its average volume of 4,260. PureTech Health has a 12-month low of $17.00 and a 12-month high of $34.00. The firm has a 50 day moving average of $20.60 and a 200 day moving average of $21.12.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.